Purpose Precise histological classification of epithelial ovarian cancer (EOC) has immanent diagnostic and therapeutic consequences, but remains challenging in histological routine. The aim of this pilot study is to examine the potential of matrix‐assisted laser desorption/ionization (MALDI) imaging mass spectrometry in combination with machine learning methods to classify EOC histological subtypes from tissue microarray. Experimental design Formalin‐fixed‐paraffin‐embedded tissue of 20 patients with ovarian clear‐cell, 14 low‐grade serous, 19 high‐grade serous ovarian carcinomas, and 14 serous borderline tumors are analyzed using MALDI‐Imaging. Classifications are computed by linear discriminant analysis (LDA), support vector machines with linear (SVM‐lin) and radial basis function kernels (SVM‐rbf), a neural network (NN), and a convolutional neural network (CNN). Results MALDI‐Imaging and machine learning methods result in classification of EOC histotypes with mean accuracy of 80% for LDA, 80% SVM‐lin, 74% SVM‐rbf, 83% NN, and 85% CNN. Based on sensitivity (69–100%) and specificity (90–99%), CCN and NN are most suited to EOC classification. Conclusion and clinical relevance The pilot study demonstrates the potential of MALDI‐Imaging derived proteomic classifiers in combination with machine learning algorithms to discriminate EOC histotypes. Applications may support the development of new prognostic parameters in the assessment of EOC.
Despite numerous diagnostic and therapeutic advances, pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate, and is the fourth leading cause of cancer death in developing countries. Besides its increasing prevalence, pancreatic malignancies are characterized by poor prognosis. Omics technologies have potential relevance for PDAC assessment but are time-intensive and relatively cost-intensive and limited by tissue heterogeneity. Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) can obtain spatially distinct peptide-signatures and enables tumor classification within a feasible time with relatively low cost. While MALDI-MSI data sets are inherently large, machine learning methods have the potential to greatly decrease processing time. We present a pilot study investigating the potential of MALDI-MSI in combination with neural networks, for classification of pancreatic ductal adenocarcinoma. Neural-network models were trained to distinguish between pancreatic ductal adenocarcinoma and other pancreatic cancer types. The proposed methods are able to correctly classify the PDAC types with an accuracy of up to 86% and a sensitivity of 82%. This study demonstrates that machine learning tools are able to identify different pancreatic carcinoma from complex MALDI data, enabling fast prediction of large data sets. Our results encourage a more frequent use of MALDI-MSI and machine learning in histopathological studies in the future.
Precise histological classification of epithelial ovarian cancer (EOC) subtypes is important for personalized treatment. The image, designed by Maria Hänel, illustrates the potential of imaging mass spectrometry combined with machine learning methods to explore spatial proteomic levels, enabling the classification of EOC histological subtypes. Applications include the development of new prognostic parameters in the tissue assessment of EOC. This is reported by Oliver Klein, Frederic Kanter, Hagen Kulbe, Paul Jank, Carsten Denkert, Grit Nebrich, Wolfgang D. Schmitt, Zhiyang Wu, Catarina A. Kunze, Jalid Sehouli, Silvia Darb‐Esfahani, Ioana Braicu, Jan Lellmann, Herbert Thiele, Eliane T. Taube in article https://doi.org/10.1002/prca.201700181.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.